Lipids & Metabolic

The American Heart Association (AHA) and the American Academy of Pediatrics (AAP) issued a joint policy statement March 25 recommending a series of public health measures aimed at reducing children’s consumption of sugary beverages.

NEW ORLEANS — A new analysis considering not only a patient's first cardiovascular event—but the second, third and beyond—paints the REDUCE-IT trial in an even more positive light. 

The CDC has released a new fact sheet on the burden of chronic kidney disease (CKD) in the U.S., highlighting its relationship to cardiovascular disease and noting that 15 percent of American adults—or 37 million people—have CKD.

A smartphone’s camera and flashlight features can detect changes in blood flow and identify type 2 diabetes with accuracy comparable to traditional, clinic-based risk scores, new research suggests.

Drug manufacturer Eli Lilly plans to offer a half-priced version of its insulin medication Humalog, the company announced March 4.

Three-quarters of patients who are diabetic and undergo Roux-en-Y gastric bypass surgery experience remission of the disease within a year of their procedure, Reuters reported of a Danish study March 1.

A literature review out of West Virginia University suggests diabetics or those at risk for diabetes and metabolic syndrome could lower that risk by sticking to a largely plant-based diet.

Women with type 2 diabetes are more likely than those without to develop more advanced, aggressive forms of breast cancer, Reuters reported of a study Feb. 27.

A new matchstick-sized continuous glucose monitor (CGM) can be implanted under the skin, allowing diabetics to track their blood sugar without the inconvenience of finger pricks and patches, according to a CBS report.

Physician bias against overweight and obese patients is not only prevalent in today’s medical landscape, according to an analysis published in JAMA Feb. 20—it could also be overshadowing quality care and driving some of those patients further from the doctor’s office.

Two U.S. senators launched a bipartisan investigation into rising insulin prices on Feb. 22, sending letters to the drug's top three manufacturers seeking information about why costs have risen so sharply in recent years.

Diabetes mellitus continues to be linked to higher all-cause and CVD mortality in patients living with the disease, according to work published in the Journal of the American Heart Association Feb. 19. But some of that risk could be mitigated by controlling cardiovascular risk factors, and diabetes-related deaths are down overall.